Serial 98471236
Live / Applied — Second extension granted (statement of use) (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 27 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98471236
- Mark type
- Non-text mark
- Filed
- 27 Mar 2024
- Published for opposition
- 18 Feb 2025
- Attorney of record
- Jennifer M. Mikulina
Goods and services
- Class 010 — Medical apparatus: Medical diagnostic instruments for diabetes diagnosis and monitoring; medical diagnostic instruments for analyzing, measuring and testing blood, bodily fluids and tissue; medical diagnostic instruments for in vitro diagnostic testing and analysis, namely, sample handlers, sample preparation equipment, equipment for testing bodily fluids for medical diagnosis; medical diagnostic instruments for microbial screening and identification, analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and pathogens; medical and surgical apparatus and instruments, namely, stents, catheters, guide wires, bioabsorbable stents, drug-eluting stents, scaffolding for catheters and stents for use in vascular procedures; medical apparatus and equipment, namely, patient monitor that is for use in electronic acquisition, capture and transmission of medical device status and patient medical and physiological data used in connection with implantable cardiac devices, and external or implantable cardiac therapeutic or diagnostic devices; medical diagnostic instruments for testing patients for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic apparatus and incorporated recorded computer software for analyzing medical data and informing treatment decisions, all sold as a unit, for medical diagnostic use; medical apparatus and instruments, namely, blood glucose meters, blood ketone meters, biosensors and biosensor applicators for measuring blood glucose, blood ketone, and blood lactate levels, electrochemical sensors for measuring analyte concentrations in interstitial fluid, electrochemical sensors for monitoring analyte levels in interstitial fluid, electrochemical sensors for monitoring analyte concentrations in bodily fluids, electrochemical sensors for monitoring analyte levels in bodily fluids, electrochemical sensors for monitoring analytes in bodily fluids, needles for injecting insulin, medical infusion pumps for delivering measured amounts of solutions into the bloodstream over time, and insulin pumps; blood, bodily fluid, tissue, and fecal matter medical testing instruments; medical apparatus for monitoring, tracking, and determining analyte concentrations; sensors for monitoring, tracking, and determining analyte concentrations for health purposes; medical apparatus and instruments for monitoring glucose; medical apparatus and instruments for monitoring ketones; instruments and apparatus for monitoring glucose for health purposes; instruments and apparatus for monitoring ketones for health purposes; patient monitoring sensors for monitoring glucose concentrations; patient monitoring sensors for monitoring ketone concentrations; sensor-based glucose monitors for medical purposes; sensor-based ketone monitors for medical purposes; medical devices, namely, catheters and catheter interface modules; medical and surgical catheters; enteral nutritional delivery system, namely, feeding tubes; breastmilk storage bottle; infant formula storage bottle, sold empty; baby bottles; baby nursers
Owner
- Abbott Laboratories, Abbott Park, IL, US
- Abbott Laboratories, Abbott Park, IL, US
Prosecution history
- 01 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2026 — SOU EXTENSION 2 GRANTED
- 31 Mar 2026 — SOU EXTENSION 2 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2025 — SOU EXTENSION 1 GRANTED
- 18 Aug 2025 — SOU EXTENSION 1 FILED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Feb 2025 — PUBLISHED FOR OPPOSITION
- 12 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED